NCT04425655View on ClinicalTrials.gov

Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.

PHASE2TerminatedINTERVENTIONAL

Enrollment

2

Participants

Timeline

Start Date

August 5, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions

Acute Myeloid Leukemia, AdultAMLAML, Adult

Interventions

DRUG

Fludarabine

30mg/m2 days 1 through 5

DRUG

Vyxeos

100U/m2 days 1, 3 5 in induction, 65U/m2 days 1 and 3 for consolidation

Trial Locations (1)

92093

UCSD Moores Cancer Center, La Jolla

Sponsors

Collaborators (1)

Jazz Pharmaceuticals

All Listed Sponsors

collaborator

Jazz Pharmaceuticals

INDUSTRY

lead

University of California, San Diego

OTHER